Connect with us

Health

MS lifeline as drug that can slow disease listed – Chinchilla News

Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.

Published

on

post featured image
ADVERTISEMENT

Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Pain Control Mechanism Could Be Exploited as a New Drug Target – Technology Networks
Coronaviruses closely related to pandemic virus found in lab freezers in Cambodia, Japan: study – Macau Business
post featured image
Most lungs recover well in 3 months after Covid: Study – Mathrubhumi English